Vasant Narasimhan | Novartis Vasant (Vas) Narasimhan, M D , has been Chief Executive Officer (CEO) of Novartis since February 1, 2018
Vasant Narasimhan - Wikipedia Vasant " Vas " Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis [1][2][3][4] He succeeded Joseph Jimenez who left Novartis in 2018 [5]
Davos 2026 | Novartis CEO Vas Narasimhan sees AI payoff for . . . - CNBCTV18 Novartis CEO Vas Narasimhan said the pharmaceutical sector is likely to see tangible benefits from artificial intelligence over the next seven to ten years, as companies deepen the use of advanced technologies across research, development and manufacturing
Vasant Narasimhan | CEO of Novartis | Leader in Global Healthcare Becoming CEO and vision for a focused pharma company Strategic Transformation: Vasant Narasimhan took over as Novartis CEO in 2018 He quickly began reshaping the company’s future Within his first month, he sold Novartis’s stake in a consumer healthcare joint venture with GSK for $13 0 billion
Novartis CEO and Key Executive Team - Craft. co Novartis's Chief Executive Officer is Vasant Narasimhan Other executives include Kees Roks, Chief Audit Officer; Harry Kirsch, Chief Financial Officer and 21 others See the full leadership team at Craft
HIGHLIGHTS: Vasant Narasimhan - CEO of Novartis | Norges Bank . . . Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, and how Novartis transformed from a sprawling conglomerate into a streamlined drug discovery company
Novartis CEO Vas Narasimhan named to 2025 TIME100 Health list Novartis has announced that CEO Vas Narasimhan, M D , has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health